BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25123274)

  • 1. The role of chromatin dynamics in immune cell development.
    Winter DR; Amit I
    Immunol Rev; 2014 Sep; 261(1):9-22. PubMed ID: 25123274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 engagement with the genome occurs in distinct local chromatin environments via pioneer factor activity.
    Sammons MA; Zhu J; Drake AM; Berger SL
    Genome Res; 2015 Feb; 25(2):179-88. PubMed ID: 25391375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early enhancer establishment and regulatory locus complexity shape transcriptional programs in hematopoietic differentiation.
    González AJ; Setty M; Leslie CS
    Nat Genet; 2015 Nov; 47(11):1249-59. PubMed ID: 26390058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic priming of enhancers predicts developmental competence of hESC-derived endodermal lineage intermediates.
    Wang A; Yue F; Li Y; Xie R; Harper T; Patel NA; Muth K; Palmer J; Qiu Y; Wang J; Lam DK; Raum JC; Stoffers DA; Ren B; Sander M
    Cell Stem Cell; 2015 Apr; 16(4):386-99. PubMed ID: 25842977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation in cell reprogramming revealed by genome-wide analysis.
    Hong CP; Park J; Roh TY
    Epigenomics; 2011 Feb; 3(1):73-81. PubMed ID: 22126154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo epigenomic profiling of germ cells reveals germ cell molecular signatures.
    Ng JH; Kumar V; Muratani M; Kraus P; Yeo JC; Yaw LP; Xue K; Lufkin T; Prabhakar S; Ng HH
    Dev Cell; 2013 Feb; 24(3):324-33. PubMed ID: 23352811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pioneer Transcription Factor FoxA Maintains an Accessible Nucleosome Configuration at Enhancers for Tissue-Specific Gene Activation.
    Iwafuchi-Doi M; Donahue G; Kakumanu A; Watts JA; Mahony S; Pugh BF; Lee D; Kaestner KH; Zaret KS
    Mol Cell; 2016 Apr; 62(1):79-91. PubMed ID: 27058788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of histone modifications across mammalian genomes: implications for 'epigenetic' marking.
    Lee BM; Mahadevan LC
    J Cell Biochem; 2009 Sep; 108(1):22-34. PubMed ID: 19623574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate Promoter and Enhancer Identification in 127 ENCODE and Roadmap Epigenomics Cell Types and Tissues by GenoSTAN.
    Zacher B; Michel M; Schwalb B; Cramer P; Tresch A; Gagneur J
    PLoS One; 2017; 12(1):e0169249. PubMed ID: 28056037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic control of inducible gene expression in the immune system.
    Lim PS; Shannon MF; Hardy K
    Epigenomics; 2010 Dec; 2(6):775-95. PubMed ID: 22122082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic regulation of epigenomic landscapes during hematopoiesis.
    Abraham BJ; Cui K; Tang Q; Zhao K
    BMC Genomics; 2013 Mar; 14():193. PubMed ID: 23510235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatin architecture reorganization during stem cell differentiation.
    Dixon JR; Jung I; Selvaraj S; Shen Y; Antosiewicz-Bourget JE; Lee AY; Ye Z; Kim A; Rajagopal N; Xie W; Diao Y; Liang J; Zhao H; Lobanenkov VV; Ecker JR; Thomson JA; Ren B
    Nature; 2015 Feb; 518(7539):331-6. PubMed ID: 25693564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel method to predict regulatory regions based on histone mark landscapes in macrophages.
    Nagy G; Dániel B; Jónás D; Nagy L; Barta E
    Immunobiology; 2013 Nov; 218(11):1416-27. PubMed ID: 23973299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of enhancer chromatin: what, how, and why?
    Calo E; Wysocka J
    Mol Cell; 2013 Mar; 49(5):825-37. PubMed ID: 23473601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenome overlap measure (EPOM) for comparing tissue/cell types based on chromatin states.
    Li WV; Razaee ZS; Li JJ
    BMC Genomics; 2016 Jan; 17 Suppl 1(Suppl 1):10. PubMed ID: 26817822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8
    He B; Xing S; Chen C; Gao P; Teng L; Shan Q; Gullicksrud JA; Martin MD; Yu S; Harty JT; Badovinac VP; Tan K; Xue HH
    Immunity; 2016 Dec; 45(6):1341-1354. PubMed ID: 27986453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of chromatin structure of the murine 3' IgH enhancer and IgG2b germline promoter in response to lipopolysaccharide and CD40 signaling.
    Qin X; Tang H
    Mol Immunol; 2006 Mar; 43(8):1211-20. PubMed ID: 16099047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenomics: Roadmap for regulation.
    Romanoski CE; Glass CK; Stunnenberg HG; Wilson L; Almouzni G
    Nature; 2015 Feb; 518(7539):314-6. PubMed ID: 25693562
    [No Abstract]   [Full Text] [Related]  

  • 19. Transcription factor binding dynamics during human ES cell differentiation.
    Tsankov AM; Gu H; Akopian V; Ziller MJ; Donaghey J; Amit I; Gnirke A; Meissner A
    Nature; 2015 Feb; 518(7539):344-9. PubMed ID: 25693565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatin accessibility and the regulatory epigenome.
    Klemm SL; Shipony Z; Greenleaf WJ
    Nat Rev Genet; 2019 Apr; 20(4):207-220. PubMed ID: 30675018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.